dc.contributor.advisor | © 2018 European Society of Endocrinology 2018 | |
dc.contributor.author | Chatterjee, S | en_US |
dc.contributor.author | Shapiro, L | en_US |
dc.contributor.author | Rose, S | en_US |
dc.contributor.author | Mushtaq, T | en_US |
dc.contributor.author | Clayton, P | en_US |
dc.contributor.author | Ten, S | en_US |
dc.contributor.author | Bhangoo, APS | en_US |
dc.contributor.author | Kumbattae, U | en_US |
dc.contributor.author | Dias, R | en_US |
dc.contributor.author | Metherell, LA | en_US |
dc.contributor.author | Savage, MO | en_US |
dc.contributor.author | Storr, H | en_US |
dc.date.accessioned | 2020-07-27T16:12:59Z | |
dc.date.issued | 2017 | en_US |
dc.identifier.issn | 1663-2818 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/65841 | |
dc.format.extent | 290 - 290 | en_US |
dc.language.iso | en | en_US |
dc.title | PHENOTYPIC SPECTRUM AND RESPONSES TO RECOMBINANT HUMAN IGF-I (RHIGF-I) THERAPY IN PATIENTS WITH HOMOZYGOUS GH RECEPTOR PSEUDOEXON DEFECTS | en_US |
dc.type | Conference Proceeding | |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000412595403161&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 88 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |
qmul.funder | Improved genetic diagnosis of primary adrenal insufficiency::Barts Charity | en_US |